Kundl, July 10, 2026

The pharmaceutical group Novartis is selling all buildings and properties of its site in Kundl, Tyrol, to the German Innexis Unternehmensgruppe, an operator specializing in pharmaceutical and life science infrastructure headquartered in Marburg.

The pharmaceutical group Novartis is selling all buildings and properties at its site in Kundl, Tyrol, to the German Innexis Unternehmensgruppe. The purchase agreement with the German group was signed on July 8, with the actual handover of the site scheduled for July 1 [date], subject to any required approvals from the competent authorities.